Working… Menu

An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF) (MusiClock)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01110993
Recruitment Status : Completed
First Posted : April 27, 2010
Last Update Posted : February 3, 2014
Information provided by (Responsible Party):
Merck KGaA, Darmstadt, Germany

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2013
Actual Study Completion Date : September 2013